Brief: Diamyd Medical Q1 Net Result Turns To Loss Of SEK 37.8 Mln
26/01/2022 12:07
Jan 26 (Reuters) -
* Q1 NET RESULT: MSEK -37.8 (104.9)
* PLAN IS TO HAVE PROCESS IN UMEÅ TESTED, VALIDATED AND GMP
CERTIFIED LATER THIS YEAR AND TO GET FACILITY APPROVED AND
PRODUCTION READY IN SECOND CALENDAR QUARTER OF 2023
Source text for Eikon: ID:nWkr2wTGkj
Further company coverage: [ ]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))